Monitor for additional insider selling in the next 30 days, if volume increases significantly, it could signal growing concern. For now, this cluster is within normal range and not a trading catalyst.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 3 $20.17entry
- T+1 · 9mo ago +2.48%α +1.72% · $20.67
- T+5 · 8mo ago −7.44%α −6.96% · $18.67
- T+20 · 8mo ago −5.40%α −1.00% · $19.08
- T+60 · 6mo ago +21.47%α +11.15% · $24.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Four C-suite executives at BioLife Solutions, including the CFO and Chief Quality and Operations Officer, sold shares in a coordinated open-market transaction on March 3, 2026, totaling $32,728 in value. The sales were small in absolute size and represent a negligible fraction of the company's $998M market cap. This appears to be routine portfolio management rather than a signal of material concern.
Key Financial Metrics
Key Facts
- Four C-suite executives sold shares on the same day (March 3, 2026) in open-market transactions.
- Total value of sales: $32,728 (aggregated across CFO, Chief Quality and Operations, Chief HR Officer, and Chief Marketing Officer).
- All transactions were coded as 'S' (open-market sale) at $20.74 per share.
- Total insider sales over the past 30 days amount to $33K, consistent with recent patterns.
Financial Impact
$32,728 in total insider sales, representing 0.0033% of market cap
Risk Factors
- Perception risk: Multiple C-suite sales on the same day may attract speculative attention despite small size.
- Lack of offsetting insider buying, no purchases in this cluster or recent history.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (4 trades, 7d window) | cluster-BLFS-1772748656000 |
Track record
15 reports on BLFS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
- Nov 6, 202610d ago Institutional Cluster Bearish 4/10 No price data
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 No price data
- Oct 16, 20264w ago 15-12G Neutral 4/10 No price data
- Oct 13, 20264w ago EFFECT Neutral 3/10 No price data
- Oct 13, 20264w ago EFFECT Neutral 3/10 No price data
- Oct 6, 20265w ago 8-K Bullish 7/10 Entry $39.00 No price data
- Sep 30, 20266w ago 425 Neutral 4/10 Entry $38.85 No price data
- Sep 30, 20266w ago DEFA14A Neutral 4/10 Entry $38.85 No price data
- Sep 24, 20267w ago SC 13G Neutral 4/10 Entry $38.58 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers